In addition, having found no or negative correlation between ALT activity and TGF-β1 levels in NASH and CHC patients, respectively, suggests that TGF-β1 is related to apoptosis rather than to inflammation. This evidence concerns the gene TGFB1 and metabolic dysfunction-associated steatohepatitis.